Thanks to CNBC’s Meg Tirrell for including comments from Toronto Memory Program’s Dr. Sharon Cohen regarding Biogen’s announcement about aducanumab data at the CTAD conference on December 6, 2019. Recording courtesy of public television station KLRU in Austin, Texas.